Cdc7-IN-9
Cdc7-IN-9 is a potent Cdc7 inhibitor and can be used for cancer research[1].
Product Specifications
CAS Number
2649407-21-4
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-9.html
Solubility
10 mM in DMSO
Smiles
CC1(NC(C2=C3C(NCCCN31)=C(S2)C4=CC=NC=N4)=O)C
Molecular Formula
C15H17N5OS
Molecular Weight
315.39
References & Citations
[1]Xianhai Huang, et al. Cyclic compounds and methods of using same, Patent WO2021113492A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6204710-01 0.1 mL
Renal Cell Carcinoma (CA-IX, CA9, CAH9_HUMAN, CAIX, Carbonate Dehydratase IX, Carbonic Anhydrase 9, Carbonic Anhydrase IX, Carbonic dehydratase, G250, Membrane antigen MN, P54/58N, pMW1, RCC-Associated antigen G250, Renal cell carcinoma-Associated antigen
Sign In for Pricing
View Details MBS6204710-02 5x 0.1 mL
Renal Cell Carcinoma (CA-IX, CA9, CAH9_HUMAN, CAIX, Carbonate Dehydratase IX, Carbonic Anhydrase 9, Carbonic Anhydrase IX, Carbonic dehydratase, G250, Membrane antigen MN, P54/58N, pMW1, RCC-Associated antigen G250, Renal cell carcinoma-Associated antigen
Sign In for Pricing
View Details 